148 related articles for article (PubMed ID: 10352613)
1. Sentinel lymph node biopsy after percutaneous diagnosis of nonpalpable breast cancer.
Liberman L; Cody HS; Hill AD; Rosen PP; Yeh SD; Akhurst T; Morris EA; Abramson AF; Borgen PI; Dershaw DD
Radiology; 1999 Jun; 211(3):835-44. PubMed ID: 10352613
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
3. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous biopsy and sentinel lymphadenectomy: minimally invasive diagnosis and treatment of nonpalpable breast cancer.
Liberman L; Cody HS
AJR Am J Roentgenol; 2001 Oct; 177(4):887-91. PubMed ID: 11566696
[TBL] [Abstract][Full Text] [Related]
5. Sentinel node biopsy for nonpalpable breast tumors requires a preoperative diagnosis of invasive breast cancer.
Rahusen FD; Meijer S; Taets van Amerongen AH; Pijpers R; van Diest PJ
Breast J; 2003; 9(5):380-4. PubMed ID: 12968957
[TBL] [Abstract][Full Text] [Related]
6. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
Crossin JA; Johnson AC; Stewart PB; Turner WW
Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
[TBL] [Abstract][Full Text] [Related]
7. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center.
O'Hea BJ; Hill AD; El-Shirbiny AM; Yeh SD; Rosen PP; Coit DG; Borgen PI; Cody HS
J Am Coll Surg; 1998 Apr; 186(4):423-7. PubMed ID: 9544956
[TBL] [Abstract][Full Text] [Related]
9. Biopsy of sentinel lymph nodes guided by lymphoscintigraphic mapping in patients with breast cancer.
Tuthill LL; Reynolds HE; Goulet RJ
AJR Am J Roentgenol; 2001 Feb; 176(2):407-11. PubMed ID: 11159082
[TBL] [Abstract][Full Text] [Related]
10. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
11. [Exclusive use of blue dye to detect sentinel lymph nodes in breast cancer].
Bühler H S; Rojas P H; Cayazzo M D; Cunill C E; Vesperinas A G; Hamilton S J
Rev Med Chil; 2008 Aug; 136(8):1015-20. PubMed ID: 18949185
[TBL] [Abstract][Full Text] [Related]
12. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM
J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
[TBL] [Abstract][Full Text] [Related]
13. [Technical aspects of sentinel node biopsy].
Hiratsuka M; Motomura K; Koyama H
Gan To Kagaku Ryoho; 2004 Feb; 31(2):275-80. PubMed ID: 14997768
[TBL] [Abstract][Full Text] [Related]
14. Technical aspects of sentinel node lymphoscintigraphy for breast cancer.
Dunnwald LK; Mankoff DA; Byrd DR; Anderson BO; Moe RE; Yeung RS; Eary JF
J Nucl Med Technol; 1999 Jun; 27(2):106-11. PubMed ID: 10353106
[TBL] [Abstract][Full Text] [Related]
15. The sentinel node in breast cancer--a multicenter validation study.
Krag D; Weaver D; Ashikaga T; Moffat F; Klimberg VS; Shriver C; Feldman S; Kusminsky R; Gadd M; Kuhn J; Harlow S; Beitsch P
N Engl J Med; 1998 Oct; 339(14):941-6. PubMed ID: 9753708
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic mapping with sentinel node biopsy in pediatric patients.
Neville HL; Andrassy RJ; Lally KP; Corpron C; Ross MI
J Pediatr Surg; 2000 Jun; 35(6):961-4. PubMed ID: 10873044
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node localization in early breast cancer.
Gulec SA; Moffat FL; Carroll RG; Serafini AN; Sfakianakis GN; Allen L; Boggs J; Escobedo D; Pruett CS; Gupta A; Livingstone AS; Krag DN
J Nucl Med; 1998 Aug; 39(8):1388-93. PubMed ID: 9708514
[TBL] [Abstract][Full Text] [Related]
18. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
[TBL] [Abstract][Full Text] [Related]
19. [Less axillary dissection necessary due to sentinel node biopsy in patients with breast carcinoma].
Meijer S; Collet GJ; Pijpers HJ; van Hattum L; Hoekstra OS
Ned Tijdschr Geneeskd; 1996 Nov; 140(45):2239-43. PubMed ID: 8984370
[TBL] [Abstract][Full Text] [Related]
20. Blue nodes left behind after vital blue dye-guided axillary sentinel node biopsy in breast cancer patients.
Cserni G; Rajtár M; Boross G
Jpn J Clin Oncol; 2000 Jun; 30(6):263-6. PubMed ID: 10939430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]